We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Madison Square Garden (MSGS) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Read MoreHide Full Article
Wall Street analysts forecast that Madison Square Garden (MSGS - Free Report) will report quarterly loss of -$0.37 per share in its upcoming release, pointing to a year-over-year decline of 134.9%. It is anticipated that revenues will amount to $149.62 million, exhibiting a decrease of 34.2% compared to the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Madison Square Garden metrics that are commonly monitored and projected by Wall Street analysts.
The combined assessment of analysts suggests that 'Total revenues from contracts with customers- Event-related' will likely reach $64.26 million. The estimate suggests a change of -57.8% year over year.
It is projected by analysts that the 'Total revenues from contracts with customers- League distributions and other' will reach $5.08 million. The estimate points to a change of -57.7% from the year-ago quarter.
Analysts forecast 'Total revenues from contracts with customers- Sponsorship, signage and suite licenses' to reach $29.22 million. The estimate indicates a year-over-year change of -15.8%.
Analysts expect 'Total revenues from contracts with customers- Media rights' to come in at $28.38 million. The estimate suggests a change of -0.1% year over year.
Shares of Madison Square Garden have experienced a change of +0.5% in the past month compared to the +1.2% move of the Zacks S&P 500 composite. With a Zacks Rank #5 (Strong Sell), MSGS is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Madison Square Garden (MSGS) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Wall Street analysts forecast that Madison Square Garden (MSGS - Free Report) will report quarterly loss of -$0.37 per share in its upcoming release, pointing to a year-over-year decline of 134.9%. It is anticipated that revenues will amount to $149.62 million, exhibiting a decrease of 34.2% compared to the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Madison Square Garden metrics that are commonly monitored and projected by Wall Street analysts.
The combined assessment of analysts suggests that 'Total revenues from contracts with customers- Event-related' will likely reach $64.26 million. The estimate suggests a change of -57.8% year over year.
It is projected by analysts that the 'Total revenues from contracts with customers- League distributions and other' will reach $5.08 million. The estimate points to a change of -57.7% from the year-ago quarter.
Analysts forecast 'Total revenues from contracts with customers- Sponsorship, signage and suite licenses' to reach $29.22 million. The estimate indicates a year-over-year change of -15.8%.
Analysts expect 'Total revenues from contracts with customers- Media rights' to come in at $28.38 million. The estimate suggests a change of -0.1% year over year.
View all Key Company Metrics for Madison Square Garden here>>>Shares of Madison Square Garden have experienced a change of +0.5% in the past month compared to the +1.2% move of the Zacks S&P 500 composite. With a Zacks Rank #5 (Strong Sell), MSGS is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .